Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Companies Make Catalyst Investments

by Alexander H. Tullo
September 20, 2010 | A version of this story appeared in Volume 88, Issue 38

Catalyst suppliers W.R. Grace and Albemarle are boosting their capacity to manufacture single-site catalysts for polyolefins. Grace has agreed to purchase fine chemicals maker Synthetech for $19.2 million. Synthetech specializes in organic synthesis, biocatalysis, and chiral technologies. Grace says that the acquisition will enable it to expand its capacity in polypropylene and specialty single-site catalysts, eliminating the need to build a new plant. The company also says Synthetech’s expertise in chiral and peptide intermediate synthesis will expand its offering in discovery sciences. Synthetech operates a plant and R&D site in Albany, Ore., and a laboratory in San Diego. Separately, Albemarle is investing in metallocene catalysts for polyolefin production in Yeosu, South Korea. The facility will be able to produce catalyst quantities suitable for customer trials later this year. Commercial-scale production of catalysts at the site will be under way by 2012.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.